BioNap
Research analyst, medium-term horizon, biotech, small-cap

CAPTURE Data Should Help Drive Soltamox Sales At DARA Bio

On February 25, 2014, DARA BioScience, Inc. (DARA) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to KRN5500 for the parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy (CCIPN) that is refractory to conventional analgesics. We see this as positive news for DARA, especially since we've been talking about this since late November 2012 when the application was first filed! We encourage investors to view our recent Seeking-Alpha article on KRN5500 to get a sense on just what gaining ODD status for the drug means.

But more important than gaining ODD status on KRN5500, and central to our thesis on the stock, is the potential for top-line acceleration and DARA's burgeoning specialty...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details